Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala - PubMed (original) (raw)

. 2005 Mar;30(3):497-507.

doi: 10.1038/sj.npp.1300535.

Affiliations

• PMID: 15280883
• DOI: 10.1038/sj.npp.1300535

Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala

Sachin Patel et al. Neuropsychopharmacology. 2005 Mar.

Abstract

Anxiety and panic are the most common adverse effects of cannabis intoxication; reactions potentiated by stress. Data suggest that cannabinoid (CB1) receptor modulation of amygdalar activity contributes to these phenomena. Using Fos as a marker, we tested the hypothesis that environmental stress and CB1 cannabinoid receptor activity interact in the regulation of amygdalar activation in male mice. Both 30 min of restraint and CB1 receptor agonist treatment (Delta9-tetrahydrocannabinol (2.5 mg/kg) or CP55940 (0.3 mg/kg); by i.p. injection) produced barely detectable increases in Fos expression within the central amygdala (CeA). However, the combination of restraint and CB1 agonist administration produced robust Fos induction within the CeA, indicating a synergistic interaction between environmental stress and CB1 receptor activation. An inhibitor of endocannabinoid transport, AM404 (10 mg/kg), produced an additive interaction with restraint within the CeA. In contrast, fatty acid amide hydrolase (FAAH) inhibitor-treated mice (URB597, 1 mg/kg) and FAAH-/- mice did not exhibit any differences in amygdalar activation in response to restraint compared to control mice. In the basolateral (BLA) and medial amygdala, restraint stress produced a low level of Fos induction, which was unaffected by cannabinoid treatment. Interestingly, the CB1 receptor antagonist SR141716 dose-dependently increased Fos expression in the BLA and CeA. These data suggest the CeA is an important neural substrate subserving the interactions between cannabinoids and environmental stress, and could be relevant to understanding the context-dependent emotional and affective changes induced by marijuana intoxication and the role of endocannabinoid signaling in the modulation of amygdalar activity.

PubMed Disclaimer

Similar articles

• Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis.
  Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ. Patel S, et al. Endocrinology. 2004 Dec;145(12):5431-8. doi: 10.1210/en.2004-0638. Epub 2004 Aug 26. Endocrinology. 2004. PMID: 15331569
• Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure.
  Hill MN, Kumar SA, Filipski SB, Iverson M, Stuhr KL, Keith JM, Cravatt BF, Hillard CJ, Chattarji S, McEwen BS. Hill MN, et al. Mol Psychiatry. 2013 Oct;18(10):1125-35. doi: 10.1038/mp.2012.90. Epub 2012 Jul 10. Mol Psychiatry. 2013. PMID: 22776900 Free PMC article.
• Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling.
  Patel S, Roelke CT, Rademacher DJ, Hillard CJ. Patel S, et al. Eur J Neurosci. 2005 Feb;21(4):1057-69. doi: 10.1111/j.1460-9568.2005.03916.x. Eur J Neurosci. 2005. PMID: 15787710
• Endocannabinoid system and stress and anxiety responses.
  Viveros MP, Marco EM, File SE. Viveros MP, et al. Pharmacol Biochem Behav. 2005 Jun;81(2):331-42. doi: 10.1016/j.pbb.2005.01.029. Pharmacol Biochem Behav. 2005. PMID: 15927244 Review.
• A neuroplasticity hypothesis of chronic stress in the basolateral amygdala.
  Boyle LM. Boyle LM. Yale J Biol Med. 2013 Jun 13;86(2):117-25. Print 2013 Jun. Yale J Biol Med. 2013. PMID: 23766733 Free PMC article. Review.

Cited by

• Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial Memory Retrieval in Rats.
  Morena M, De Castro V, Gray JM, Palmery M, Trezza V, Roozendaal B, Hill MN, Campolongo P. Morena M, et al. J Neurosci. 2015 Oct 14;35(41):13962-74. doi: 10.1523/JNEUROSCI.1983-15.2015. J Neurosci. 2015. PMID: 26468197 Free PMC article.
• Developmental regulation of fear learning and anxiety behavior by endocannabinoids.
  Lee TT, Hill MN, Lee FS. Lee TT, et al. Genes Brain Behav. 2016 Jan;15(1):108-24. doi: 10.1111/gbb.12253. Epub 2015 Nov 5. Genes Brain Behav. 2016. PMID: 26419643 Free PMC article. Review.
• Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions through conditional genetic rescue in forebrain GABAergic neurons.
  Remmers F, Lange MD, Hamann M, Ruehle S, Pape HC, Lutz B. Remmers F, et al. Brain Struct Funct. 2017 Nov;222(8):3431-3452. doi: 10.1007/s00429-017-1411-5. Epub 2017 Apr 9. Brain Struct Funct. 2017. PMID: 28393261 Free PMC article.
• Neurobiological Interactions Between Stress and the Endocannabinoid System.
  Morena M, Patel S, Bains JS, Hill MN. Morena M, et al. Neuropsychopharmacology. 2016 Jan;41(1):80-102. doi: 10.1038/npp.2015.166. Epub 2015 Jun 12. Neuropsychopharmacology. 2016. PMID: 26068727 Free PMC article. Review.
• The endocannabinoid system as an emerging target of pharmacotherapy.
  Pacher P, Bátkai S, Kunos G. Pacher P, et al. Pharmacol Rev. 2006 Sep;58(3):389-462. doi: 10.1124/pr.58.3.2. Pharmacol Rev. 2006. PMID: 16968947 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Medical

  • MedlinePlus Health Information